For most of the world, Cindy Crawford has always been the woman who wakes up looking perfect — the luminous skin, the iconic mole, the effortless confidence of someone who has stood in front of cameras since the 1980s and never once seemed to blink. Yet behind that flawless public image, the legendary supermodel spent the better part of a decade quietly grappling with a condition that was literally pulling her eyes downward, dimming the very feature that had helped make her face one of the most recognizable on earth.

Now, at 60 years old, Crawford is finally telling the full story — and in doing so, she is offering something far more valuable than beauty tips: she is offering honesty.

In a candid, deeply personal interview with People magazine, Crawford opened up about living with ptosis — a medical condition that causes one or both eyelids to droop — for approximately ten years. She described the quiet frustration of noticing that her eyes no longer looked the way they once did on camera, the workarounds her makeup team developed to compensate, and the moment two years ago when a simple recommendation from her dermatologist changed everything.

The conversation has resonated deeply with fans and women across generations, not only because it lifts the lid on a condition that affects millions globally, but because of the broader message Crawford is sending: aging is not something to be hidden, and self-care is not vanity — it is dignity.

The Morning She First Noticed Something Was Different
Cindy Crawford has spent her entire adult life in the public eye, which means she has spent decades being hyper-aware of her appearance — not out of vanity, but out of professional necessity. In the modeling world, every millimeter of a face is scrutinized under high-resolution cameras, unforgiving studio lights, and the lens of photographers who are paid to capture perfection. So when she began noticing subtle changes in how her eyes looked on camera, it was not the kind of thing she could simply dismiss.

The realization crept up on her gradually, as these things often do. It was not a single dramatic moment, but rather an accumulation of small, nagging observations — a shoot where the lighting caught her eyelids at an angle that looked heavier than usual, a morning when a makeup artist leaned in close and delicately used their fingers to lift her lids before applying shadow, a photograph where her gaze looked less electric than she remembered it being. “I remember about 10 years ago, after turning 50, whenever I had an early morning shoot, people would ask: ‘Are you okay to start at 6:00 AM?’” Crawford told People, recounting the early days of her struggle.

“I responded that I can wake up whenever they want, but my face doesn’t really wake up until 9:00 AM, so don’t plan any close-ups or anything.” There is something both humorous and poignant about that quote — humor, because it captures the wry self-awareness of a woman who has always been comfortable with her own image; poignancy, because underneath the joke is a real story of a professional dealing with a physical limitation she did not yet fully understand and had not yet been able to name.

Crawford also recalled noticing that, whenever she was on camera during those early morning sessions, her eyes simply were not performing the way they used to.

They were not as dynamic, not as fresh, not as alive-looking as they had been in her thirties and forties. In the modeling world, the eyes are everything — they are the focal point of nearly every beauty photograph, the windows through which a model communicates emotion, energy, and allure. For Crawford, whose eyes had always been one of her most celebrated features, the change was not just cosmetic.

It was personal. To understand what Crawford has been dealing with for the past decade, it helps to understand the science behind the condition. Ptosis — pronounced TOE-sis, from the Greek word for “falling” — is a medical term referring to the drooping or falling of the upper eyelid.

What Is Ptosis? Understanding the Condition Behind the Drooping Lids
It can affect one or both eyes, can be mild or severe, and can develop gradually or appear suddenly. The full medical name for the condition is blepharoptosis, derived from the Greek words for “eyelid” and “falling.” According to the Cleveland Clinic, ptosis most commonly occurs when the levator muscle — the muscle responsible for lifting the upper eyelid — does not function properly.

In some cases, this is because the muscle itself is weak or damaged. In other cases, the tendon connecting the levator muscle to the eyelid stretches or becomes loose over time. In either scenario, the result is an eyelid that does not lift as high as it should, creating a drooping appearance.

There are several distinct types of ptosis, and understanding them is key to understanding why the condition is so common yet so often goes undiagnosed. Congenital ptosis is present from birth and occurs when the levator muscle does not develop properly in utero. Aponeurotic ptosis — the type most commonly associated with aging — occurs when the tendon that connects the levator muscle to the eyelid stretches or detaches over time.

This is sometimes called “senile ptosis” or age-related ptosis, and it is by far the most prevalent form in adults over the age of 50. Neurogenic ptosis arises from nerve damage or neurological conditions, while myogenic ptosis is associated with disorders that affect the muscles themselves, such as myasthenia gravis. The severity of ptosis can vary enormously.

In mild cases, the drooping may be barely perceptible and cause no significant visual impairment — though it may still have cosmetic and emotional effects on the person experiencing it. In more severe cases, the eyelid may droop low enough to cover the pupil, partially or even completely obstructing vision. When ptosis is severe enough to impair sight, it becomes not just a cosmetic concern but a genuine medical necessity requiring treatment.

According to medical literature, ptosis affects people of all ages, all genders, and all backgrounds, though it is significantly more common in older adults. Studies suggest that aponeurotic ptosis affects as many as one in three adults over the age of 50 to varying degrees, though many cases go undiagnosed because the drooping is mild enough that people attribute it simply to tiredness or aging and do not seek medical attention.

Women, in particular, are often more likely to notice and be affected by the cosmetic dimensions of the condition, particularly if they work in industries — such as modeling, acting, or media — where their appearance is central to their professional life.

The condition can also have significant psychological and emotional effects. Research has shown that people with ptosis — even mild ptosis — are frequently perceived by others as tired, disinterested, sad, or unwell, regardless of how they actually feel. Over time, this persistent misreading of one’s emotional state by others can take a real toll on self-confidence and social interactions.

Many people with ptosis report feeling frustrated that their outward appearance does not match their inner energy level, or that they are constantly being asked if they are feeling alright when they feel perfectly fine.

For Cindy Crawford, the decade she spent living with ptosis before receiving formal guidance was defined largely by adaptation. In the modeling world, adaptation is something of a survival skill — professionals in the industry learn quickly to work with what they have, and the teams surrounding them learn just as quickly how to compensate for any perceived shortcomings.

A Decade in Makeup Chairs: The Workarounds and the Worries
In Crawford’s case, that compensation came largely at the hands of skilled makeup artists. Crawford revealed that makeup artists often had to physically lift her eyelids during beauty sessions — a practice that, while effective, speaks to the very real practical implications the condition was having on her professional work.

The technique, commonly used by makeup artists working with clients who have ptosis or heavy eyelids, involves gently pressing upward on the eyelid skin to simulate the lifted appearance of a more youthful eye before applying eyeshadow, liner, and other products.

It is a skilled maneuver, and in the right hands, it can produce stunning results. But it is also a workaround — a way of managing a condition rather than addressing it. Beyond the practical workarounds in the makeup chair, Crawford also had to adapt her professional schedule and set expectations accordingly.

The instruction she gave to production teams — no close-ups before 9 AM, schedule shoots later in the morning when possible — reflects a kind of quiet, pragmatic negotiation that many professionals dealing with health conditions learn to make over time. It is not surrender; it is strategy.

And it is worth noting that Crawford continued to work at the very highest levels of her profession throughout this entire period, shooting campaigns, gracing magazine covers, and maintaining the kind of career longevity that few models achieve.

Still, there is something deeply human about the picture Crawford paints — the legendary supermodel, one of the most photographed women of the 20th century, quietly asking photographers not to zoom in on her face before her eyes have had a chance to wake up. It is a reminder that the gap between the image we project publicly and the reality of our private lives can be enormous, and that even the most seemingly invulnerable people are navigating their own hidden struggles. Crawford has never been someone who pretended that beauty came without effort.

Throughout her career, she has been remarkably candid about the work that goes into maintaining her appearance — the fitness routines, the skincare regimens, the role of professional makeup and lighting in shaping the images that reach the public. But ptosis was different. It was not something she could train away or moisturize into submission.

It was a physical condition with biological roots, and it required a medical solution. What strikes many readers about Crawford’s story is not just the condition itself, but the length of time it took her to find a treatment that worked. By her own account, she spent approximately eight years living with ptosis — adapting to it, working around it, managing it cosmetically — before she learned about Upneeq, the prescription eye drop that has since become part of her daily routine.

Eight Years of Searching: The Long Road to Finding Upneeq
The discovery came not from a specialist visit or a medical deep-dive, but from a recommendation by her dermatologist — a reminder that sometimes the most significant health breakthroughs come through the most unexpected channels. “About two years ago, my dermatologist recommended those drops to me as a way to help my eyes look a bit more open and awake.

So I tried it,” Crawford said in her People interview. Upneeq — the brand name for oxymetazoline hydrochloride ophthalmic solution 0.1% — was approved by the U.S. Food and Drug Administration in 2020, making it a relatively recent addition to the treatment landscape for ptosis.

It was the first and, at the time of its approval, only prescription eye drop specifically indicated for acquired blepharoptosis in adults. The drug works by stimulating the Müller’s muscle, a smooth muscle in the upper eyelid that works in conjunction with the levator muscle to keep the eyelid elevated. By activating this muscle, the eye drop produces a visible lifting effect that can make the eyes appear more open and alert.

Crawford has described the effect as working in less than five minutes, with results lasting up to eight hours. This pharmacological mechanism — rapid onset, predictable duration, non-invasive application — makes Upneeq particularly appealing to people who want to manage their ptosis without surgery. For professionals like Crawford, whose schedules are unpredictable and who need to look camera-ready on short notice, the convenience of a once-daily eye drop that works quickly and reliably is transformative.

Currently, Crawford uses the eye drops every day, typically around 9:30 in the morning. The specificity of that timing is itself revealing — it suggests a thoughtful integration of the treatment into her daily routine, timed to coincide with the point in her morning when she is typically beginning her professional day in earnest. For a woman who has spent a decade learning to manage the rhythm of her condition, the ability to simply apply drops and know that her eyes will look their best for the hours ahead represents a significant improvement in quality of life.

It is worth noting, however, that Upneeq is not a cure for ptosis. It does not address the underlying cause of the condition — the weakening of the levator muscle or the stretching of the aponeurosis — and its effects are temporary, requiring daily application to maintain. For patients with severe ptosis, or for those whose ptosis is caused by neurological or myogenic factors, surgical intervention may still be necessary.

But for the many people with mild to moderate age-related ptosis — the population Crawford belongs to — it represents a genuine medical advance that can meaningfully improve both appearance and confidence. The approval of Upneeq in 2020 marked a significant moment in ophthalmology and aesthetic medicine. For decades, the primary treatment options for ptosis were limited: either surgical correction or no treatment at all.

Upneeq: The Science, the Studies, and the Growing Conversation Around Ptosis Treatment
Surgery, while often effective, carries the risks and recovery time of any invasive procedure, and is not appropriate for all patients. Many people with mild ptosis — who experience cosmetic effects but no significant visual impairment — were in a gray zone where surgery felt like overkill but no meaningful non-surgical option existed. The development of Upneeq changed that calculus.

Clinical trials demonstrated that a single daily application of the oxymetazoline solution produced statistically significant lifting of the upper eyelid compared to placebo, with the effect typically appearing within 15 minutes of application and lasting throughout the day. Side effects were generally mild and included headache, conjunctival hyperemia (eye redness), dry eye, blurred vision, and punctate keratitis (tiny scratches on the cornea), though these occurred in a minority of patients and were typically transient.

The approval sparked a broader conversation within the medical community about the underdiagnosis of ptosis and the potential demand for non-surgical interventions.

Many ophthalmologists and oculoplastic surgeons began noting that ptosis is far more common than most people realize — affecting not just older adults but also contact lens wearers (in whom prolonged use can stretch the levator aponeurosis), individuals who frequently rub their eyes, and people who have had repeated eye surgeries. The conversation was also complicated by questions of coverage and access. In the United States, insurance coverage for ptosis treatment — including Upneeq — depends heavily on whether the drooping is deemed medically necessary versus cosmetically motivated.

For patients whose ptosis significantly impairs their vision, coverage is generally more accessible. For those whose ptosis is primarily cosmetic, out-of-pocket costs can be substantial. Upneeq, as a brand-name prescription drug, carries a price tag that puts it out of reach for many patients without insurance support.

Crawford’s public discussion of the drug has inevitably brought it additional attention and, with it, additional scrutiny. Some commentators have noted the importance of consulting with a qualified eye care professional before using Upneeq, as the drug is contraindicated in certain patients, including those taking monoamine oxidase inhibitors and those with certain types of glaucoma.

As with any prescription medication, the decision to use Upneeq should be made in consultation with a healthcare provider who can evaluate the patient’s full medical history and eye health.

Confidence, Womanhood, and the Power of Looking Like Yourself
What elevates Crawford’s story beyond a simple celebrity health disclosure is the context in which she frames it. She is not talking about vanity. She is not talking about chasing youth or holding back the clock at all costs.

She is talking about something more fundamental and more human: the desire to look on the outside the way she feels on the inside, and the confidence that comes from knowing that her appearance reflects her actual energy level and spirit rather than a medical condition she cannot control. “It’s one of those little things we can do to feel like our best selves,” Crawford told People. “When women feel more confident, they present themselves to the world in a better way.”

That quote deserves unpacking, because it contains a philosophy that is relevant far beyond the specific context of ptosis treatment. Crawford is articulating something that women across cultures and generations have long understood intuitively but that is sometimes dismissed as superficial: the connection between appearance and confidence is real, and tending to one’s appearance — within the bounds of health, sanity, and self-respect — is a legitimate form of self-care.

 

This is a nuanced position in a cultural moment that tends toward extremes — either the celebration of bold, dramatic cosmetic interventions or the rejection of beauty work altogether in the name of “natural aging.”

Crawford is staking out a middle ground that feels authentic to who she has always been: a woman who cares about her appearance, who invests in her health and grooming, but who is not willing to distort herself beyond recognition in the pursuit of an unachievable ideal.

Her comments about confidence and womanhood also touch on something broader about how women are perceived in professional and social contexts. Research consistently shows that drooping eyelids — regardless of the cause — lead others to perceive the affected person as tired, sad, or disengaged.

For a professional whose entire livelihood depends on projecting energy, vitality, and presence, managing that perception is not vanity; it is professional competence. And for any woman navigating a world that has historically been quick to dismiss or sideline older women, looking alert and engaged is a form of self-advocacy.

Cindy Crawford turned 60 in February 2025, and by all accounts she has been doing so on her own terms — with characteristic elegance, honesty, and a healthy dose of pragmatism.

Turning 60: Crawford’s New Philosophy on Beauty and Aging
Her milestone birthday prompted a wave of media attention and reflection, much of it focused on how she has managed to maintain such remarkable longevity in an industry that has a well-documented tendency to discard women the moment they pass a certain age.

But Crawford has been at pains to push back against any narrative that frames her ongoing career as a triumph of anti-aging. In interview after interview around her 60th birthday, she has been explicit about the fact that she is not trying to look younger than she is — she is trying to look like the best version of herself at the age she actually is.

It is a distinction that sounds simple but carries enormous weight in a culture that often conflates those two things. “Honestly, I’m not trying to look 20 or 25 anymore. That’s the biggest shift in how I view beauty. I just want to be the best version of myself,” she said in her People interview. “I don’t want to look tired. I also don’t want people to feel like I’m trying too hard to hold onto my youth.”

This is a philosophy that Crawford has been developing and articulating for some years now, and it has resonated enormously with her fans — particularly women in their forties, fifties, and sixties who are navigating the same questions she is. How do you age with grace and authenticity? How do you take care of yourself without becoming a slave to the pursuit of youth?

How do you acknowledge the reality of what aging does to your body while still presenting your best self to the world? Crawford does not pretend that aging is easy. She has acknowledged that it “comes with many challenges,” and the revelation about her decade-long battle with ptosis is itself a window into the very real physical dimensions of those challenges.

But she consistently frames those challenges as things to be navigated thoughtfully rather than either denied or surrendered to. Her approach to fitness and health as she ages has been equally pragmatic. She has spoken in other interviews about shifting her exercise focus away from intense cardio and toward strength training and Pilates, not in pursuit of a certain aesthetic, but in service of function — staying strong, mobile, and energetic as her body changes.

The same practical philosophy extends to her skincare, her diet, and now her approach to managing ptosis: find what works, use it consistently, and move on. One of the things that has made Cindy Crawford such an enduring figure — beyond her undeniable physical beauty and professional success — is her willingness to be honest about the reality of her life in ways that other celebrities often are not. From early in her career, she was a pioneer in discussing the gap between the images produced in fashion photography and the reality of human bodies.

The Supermodel as Role Model: Crawford’s Legacy of Honesty
She famously said, long before the era of body positivity as a cultural movement, that even she doesn’t wake up looking like Cindy Crawford — meaning the idealized, airbrushed version of herself that appeared on magazine covers. That commitment to honesty has deepened as she has aged. Crawford has been candid about the cosmetic procedures she has had — and equally candid about the lines she has not crossed.

She has spoken openly about the social and psychological pressures that come with aging in the public eye, and about the ongoing negotiation between self-acceptance and self-improvement that defines the experience of many women in midlife. Her willingness to name ptosis specifically, to describe its practical effects on her professional life, and to discuss the treatment she has found effective is entirely consistent with this long-standing pattern. In an era of social media perfection — where celebrities and influencers present meticulously curated versions of their lives, and where even “authenticity” is often carefully staged — Crawford’s brand of honesty feels refreshing and genuinely countercultural.

She is not performing vulnerability; she is demonstrating it. And that distinction matters enormously to the millions of women who follow her and look to her not just for beauty inspiration but for a model of how to age with dignity and self-possession. The response to her ptosis revelation has been overwhelmingly positive, with many fans thanking her for bringing awareness to a condition they either have themselves or recognize in older family members.

Ophthalmologists and eye care professionals have also welcomed the attention, noting that ptosis is frequently underdiagnosed precisely because people assume that drooping eyelids are simply “part of aging” and do not realize that treatment options — including effective non-surgical options — exist.

While Crawford’s case represents the most common form of ptosis — age-related aponeurotic ptosis that develops gradually after the age of 50 — it is important to understand that the condition can and does affect people of all ages and in a variety of different circumstances. Raising awareness about the broader landscape of ptosis is one of the most valuable contributions that a story like Crawford’s can make.

Ptosis Beyond Aging: Who Else Is Affected and What They Can Do
Congenital ptosis, as mentioned earlier, is present from birth and affects approximately one in 800 newborns. It occurs when the levator muscle fails to develop normally during fetal development. Unlike age-related ptosis, congenital ptosis often requires relatively early intervention — particularly when the drooping is severe enough to obstruct vision during the critical developmental period of early childhood.

Untreated severe congenital ptosis can lead to amblyopia (commonly known as lazy eye) and permanent vision impairment, which is why early diagnosis and treatment are so important. Contact lens wearers represent another population at elevated risk of ptosis. Long-term contact lens wear — particularly the use of rigid gas-permeable lenses — can gradually stretch the levator aponeurosis, leading to aponeurotic ptosis that may appear similar in presentation to age-related ptosis but occurs in younger patients.

This form of ptosis has become increasingly recognized as contact lens use has become ubiquitous, and it serves as a reminder that lifestyle factors can play a role in the development of the condition. Ptosis can also be a symptom of underlying neurological or systemic conditions, which is why any new or rapidly developing ptosis should be evaluated by a healthcare professional. Horner syndrome — caused by a disruption of the sympathetic nerve supply to the eye — can cause ptosis along with other signs including a smaller pupil on the affected side.

Oculomotor nerve palsy, which can result from a brain aneurysm, tumor, or diabetic nerve damage, can cause ptosis alongside other eye movement abnormalities. Myasthenia gravis, an autoimmune condition that affects the neuromuscular junction, frequently causes ptosis as one of its cardinal features. For this reason, ptosis that develops suddenly, that is accompanied by double vision, or that varies in severity throughout the day should always prompt a thorough medical evaluation.

Treatment options for ptosis have expanded considerably in recent years. At the non-surgical end of the spectrum, Upneeq (oxymetazoline) represents the first FDA-approved pharmacological option for acquired blepharoptosis. Ptosis crutches — small attachments to eyeglass frames that physically support the drooping eyelid — are another non-surgical option, though they are generally considered less aesthetically desirable and are more commonly used as a temporary measure or for patients who are not surgical candidates.

Surgical options include levator resection — in which the levator muscle is shortened to increase its lifting power — and frontalis sling surgery, in which a sling is created to connect the eyelid to the frontalis muscle in the forehead, allowing the patient to lift the eyelid by raising their eyebrows. The choice of surgical technique depends on the severity of the ptosis and the degree of levator muscle function remaining. Crawford’s decision to publicly disclose her ptosis battle is significant beyond the specifics of the condition.

The Broader Conversation: Women, Health, and the Courage to Speak Out
It is part of a broader and increasingly important conversation about women’s health, the courage required to disclose health challenges publicly, and the value of celebrity platforms in raising awareness about medical conditions that affect millions of people but receive relatively little public attention.

Over the past several years, a growing number of high-profile women have used their platforms to discuss health conditions that had previously been stigmatized or simply underdiscussed. Selma Blair’s public disclosure of her multiple sclerosis diagnosis, Christy Brinkley’s discussions of aging and joint health, and numerous other celebrities’ candid health discussions have all contributed to shifting the cultural conversation around women’s health in meaningful ways.

What makes these disclosures powerful is not just the information they convey — though that information is genuinely valuable — but the normalization they accomplish. When a woman as accomplished and admired as Cindy Crawford says, “I have this condition, it affected my professional life, and here is what I found to help,” she gives permission to millions of other women to acknowledge similar experiences without shame or embarrassment. She models the behavior of seeking help, discussing medical realities openly, and integrating health management into daily life without apology.

At the same time, it is worth acknowledging the complexity of this kind of celebrity health disclosure. Celebrities who discuss medical conditions are inevitably intertwined with commercial interests — in Crawford’s case, the mention of Upneeq by name has raised questions about whether she has any commercial relationship with the manufacturer of the drug. These are legitimate questions, and readers are always well-served by approaching celebrity health endorsements with appropriate critical awareness.

What is beyond dispute, however, is that ptosis is a real condition, that it affects millions of people, and that effective treatment options — including Upneeq — exist and may be unknown to many of those who would benefit from them. Perhaps the most powerful dimension of Cindy Crawford’s ptosis revelation is the way it democratizes a health experience that is anything but exclusive. Ptosis does not care whether you are a legendary supermodel or an accountant in Toledo.

What Crawford’s Story Means for Everyday Women
It does not care whether your face has appeared on ten thousand magazine covers or has only ever been photographed at family reunions. It is a biological process — the gradual weakening of a small but essential muscle — that affects people across every demographic. For the many women who have spent years noticing that their eyes look heavier or more tired than they used to, who have been told repeatedly that they look exhausted when they feel perfectly fine, who have stood in front of mirrors wondering why their face no longer reflects the energy they feel inside, Crawford’s story is an invitation.

It is an invitation to consider that what they have been experiencing has a name, that it has a cause, and that it has treatments — some simple and non-invasive, others more involved, but all deserving of attention and care. It is also an invitation to have a conversation with a healthcare provider. Ptosis — particularly mild to moderate ptosis — is frequently dismissed by patients who assume it is simply “part of aging” and therefore not worth mentioning to a doctor.

Crawford’s story is a reminder that that assumption may be wrong, and that a simple conversation with a dermatologist, ophthalmologist, or primary care physician could lead to a recommendation — as it did in her case — that makes a meaningful difference.

The practical takeaway from Crawford’s experience is simple: if you have noticed changes in your eyelids, if you are frequently told that you look tired when you do not feel tired, or if drooping eyelids are affecting your confidence or your professional life, talk to a doctor. A thorough eye examination can determine whether ptosis is present, assess its severity, identify any underlying causes that need to be addressed, and lay out the treatment options available — from watchful waiting to eye drops to surgery, depending on the degree of the problem.

At 60, Crawford Has Never Been More Herself
There is something quietly revolutionary about a woman who has spent forty years being held up as a physical ideal choosing to spend her sixtieth birthday talking about a drooping eyelid. It is not the conversation anyone would have scripted for the woman who once posed for the cover of Playboy, who launched a thousand product campaigns on the strength of her impossibly symmetrical face, who became so synonymous with beauty that the expression “waking up looking like Cindy Crawford” entered the cultural lexicon as shorthand for impossible perfection. But it is, in many ways, the most Cindy Crawford thing she could possibly do.

Because the Crawford who has always resonated most deeply with people is not the airbrushed icon — it is the real woman behind the image. The woman who does bodyweight exercises in her living room. The woman who posts makeup-free selfies on social media.

The woman who tells a photographer not to schedule close-ups before 9 AM because her face hasn’t woken up yet. That woman — funny, pragmatic, self-aware, and deeply human — has always been the most interesting and compelling version of Cindy Crawford. In revealing her decade-long struggle with ptosis, Crawford is doing what she has done throughout her career at its best: closing the gap between image and reality, refusing to let the perfected public persona crowd out the actual human being.

And in doing so, she is delivering something far more valuable than any magazine cover or beauty campaign ever could — a reminder that the goal of beauty, at its most meaningful, is not to look like someone else’s idea of perfection but to look and feel like the best possible version of yourself. “I don’t want to look tired. I also don’t want people to feel like I’m trying too hard to hold onto my youth,” she said. In that sentence is the distillation of a philosophy it has taken Crawford sixty years to fully articulate — and that many women spend their whole lives searching for.

Look like yourself. Take care of yourself. Be honest about the journey.

And never, under any circumstances, schedule close-ups before 9 AM. As Crawford’s story reverberates across social media and health circles, researchers and clinicians in the field of oculoplastic surgery and ophthalmology are watching with interest. Increased public awareness of ptosis could have significant downstream effects — not just on patient help-seeking behavior, but on research funding, insurance coverage decisions, and the development of new treatments.

Looking Ahead: The Future of Ptosis Treatment and the Aging Conversation
The pipeline for ptosis treatment is active. Researchers are exploring new pharmacological approaches, including drugs that target different components of the eyelid-lifting mechanism and formulations that might offer longer duration of action than current options. Advances in minimally invasive surgical techniques — including scarless approaches and outpatient procedures performed under local anesthesia — are also making surgical correction more accessible to patients who might previously have been deterred by the perceived invasiveness or recovery time of traditional ptosis surgery.

At the same time, the broader conversation about aging in America — and about how women in particular are expected to age — continues to evolve. The rigid binary between “aging gracefully” (meaning, accepting visible signs of aging without intervention) and “fighting aging” (meaning, pursuing treatments aggressively) is giving way to something more nuanced: the idea that individuals should be empowered to make their own choices about how they manage the physical changes that come with aging, armed with accurate medical information and free from both pressure to intervene and pressure to abstain. Crawford, at 60, is embodying that nuanced middle ground better than almost anyone in the public eye.

She is not pretending she hasn’t aged; she is not exhausting herself trying to reverse it. She is paying attention to her body, seeking professional guidance when something changes, using effective treatments when they are available, and moving through the world with the kind of confidence that has always been her most magnetic quality — the confidence not of someone who looks perfect, but of someone who looks like herself.

In the end, that may be Cindy Crawford’s greatest beauty secret: not a particular skincare regimen or a specific eye drop or a carefully crafted workout routine, but the willingness to be honest — with herself, with her team, with the millions of people who have been watching her face for four decades — about what she sees in the mirror, what she struggles with, and what she has found to help.

It is a gift she has been giving her whole career. It is one that, at 60, she is still generously giving. If you have noticed drooping of one or both upper eyelids, or if you have been told repeatedly that you look tired or unwell despite feeling fine, consider scheduling an appointment with an ophthalmologist or oculoplastic surgeon for a comprehensive eye examination.

A Note on Ptosis and When to See a Doctor
Ptosis can be mild and primarily cosmetic, or it can be an indicator of an underlying condition that requires further evaluation. A qualified eye care professional can assess the degree of drooping, evaluate levator muscle function, check for any associated conditions, and discuss the full range of treatment options available to you — from observation to prescription eye drops to surgical correction. Early evaluation is always preferable, and treatment — when appropriate — can have a meaningful positive impact on both vision and quality of life.

Upneeq (oxymetazoline hydrochloride ophthalmic solution 0.1%) is a prescription medication. It should only be used under the guidance of a licensed healthcare provider. Consult your doctor before starting any new medication.